Key metrics and charts across all fundamental categories.
Stock price and market valuation
HCA trades at $387.76, a 12.2% increase year-over-year. Market capitalization stands at $86.70B, up 1.6% from the prior year. Track HCA price trends and market cap history to understand how the market values this company over time.
Revenue and earnings growth across quarters
$76.39B in TTM revenue grew 6.7% YoY, reaching $19.11B last quarter. TTM EBITDA of $13.38B on operating income of $2.29B shows growth is flowing through. Net income of $6.79B TTM confirms the company is converting revenue into profit. Revenue is growing at a healthy pace — a signal to hold.
Assets, cash, debt, and leverage
Price multiples and return ratios
At 12.8x P/E, the stock trades below market averages — potentially undervalued. P/S of 1.1x and P/B of 0.0x provide additional context. Below-market P/E with growing revenue suggests a potential buying opportunity — the stock may be undervalued relative to its fundamentals.
Operating efficiency and return metrics
Op. margin of 12.0% is down 0.7% YoY — costs are rising relative to revenue. Net margin at 8.5%.
Free cash flow, earnings quality, and capital allocation
FCF of $895.00M on $2.01B in operating cash flow. The FCF / Net Income ratio of 0.1x indicates partial cash conversion — earnings quality needs attention. Cash reserves of $940.00M provide financial flexibility. Shares outstanding declined 9.5% YoY — buybacks are returning capital to shareholders.
